B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis | Zendy

Abdellaziz Dahou | Zendy; MarieAnnick Clavel | Zendy; Romain Capoulade | Zendy; Kim O’Connor | Zendy; Henrique Barbosa Ribeiro | Zendy; Nancy Côté | Zendy; Florent Le Ven | Zendy; Josep RodésCabau | Zendy; Jean G. Dumesnil | Zendy; Patrick Mathieu | Zendy; Philippe Pîbarot | Zendy

Open Access

B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis

Author(s) -

Abdellaziz Dahou,

MarieAnnick Clavel,

Romain Capoulade,

Kim O’Connor,

Henrique Barbosa Ribeiro,

Nancy Côté,

Florent Le Ven,

Josep RodésCabau,

Jean G. Dumesnil,

Patrick Mathieu,

Philippe Pîbarot

Publication year - 2018

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2017.06.018

Subject(s) - medicine , cardiology , ejection fraction , natriuretic peptide , brain natriuretic peptide , stenosis , group b , heart failure

The objective of this study was to determine the prognostic value of combined measures of B-type natriuretic peptide (BNP) and high-sensitivity cardiac troponin T (hsTnT) in patients with low-flow, low-gradient aortic stenosis (LF-LG AS) who had either a preserved or reduced left ventricular ejection fraction (LVEF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research